Specifically, we used routinely available clinicopathological (tumor size, histologic grade, or nodal involvement) and IHC (ER, PR, HER2, and KI67) parameters to compute the NPI and IHC4 score and investigated relationships with breast cancer risk factors. The gene discussed is PGR; the disease is breast cancer.